Polyinosinic-polycytidylic acid limits tumor outgrowth in a mouse model of metastatic lung cancer

Journal of Immunology

Volumn 188, Issue 11, 2012, Pages 5357-5364

  Forte, Giovanni ^a   Rega, Alessia ^a   Morello, Silvana ^a   Luciano, Antonio ^b   Arra, Claudio ^b   Pinto, Aldo ^a   Sorrentino, Rosalinda ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MONOCLONAL ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LUNG; LUNG METASTASIS; LYMPH NODE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN; TUMOR REGRESSION;

ADOPTIVE TRANSFER; ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; POLY I-C;

EID: 84862059630     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103811     Document Type: Article

References (25)

1. Pinto, A., S. Morello, and R. Sorrentino. 2011. Lung cancer and Toll-like receptors. Cancer Immunol. Immunother. 60: 1211-1220.
2. Igney, F. H., and P. H. Krammer. 2002. Immune escape of tumors: apoptosis resistance and tumor counterattack. J. Leuk. Biol. 71(6): 907-920.
3. Prendergast, G. C. 2008. Immune escape as a fundamental trait of cancer: focus on IDO. Oncogene 27: 3889-3900. (Pubitemid 351913639)
4. Gnjatic, S., N. B. Sawhney, and N. Bhardwaj. 2010. Toll-like receptor agonists: are they good adjuvants? Cancer J. 16: 382-391.
5. Kool, M., T. Soullié, M. van Nimwegen, M. A. Willart, F. Muskens, S. Jung, H. C. Hoogsteden, H. Hammad, and B. N. Lambrecht. 2008. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205: 869-882. (Pubitemid 351549884)
6. Kawai, T., and S. Akira. 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21: 317-337.
7. Kwissa, M., S. P. Kasturi, and B. Pulendran. 2007. The science of adjuvants. Expert Rev. Vaccines 6: 673-684. (Pubitemid 47607845)
8. Trumpfheller, C., M. Caskey, G. Nehinda, M. P. Longhi, O. Mizenina, Y. Huang, S. J. Schlesinger, M. Colonna, and R. M. Steinman. 2008. The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine. Proc. Natl. Acad. Sci. USA 105: 2574-2579. (Pubitemid 351520555)
9. McCartney, S. M., W. Vermi, S. Gilfillan, M. Cella, T. L. Murphy, R. D. Schreiber, K. M. Murphy, and M. Colonna. 2009. Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells. J. Exp. Med. 206: 2967-2976.
10. Akazawa, T., T. Ebihara, M. Okuno, Y. Okuda, M. Shingai, K. Tsujimura, T. Takahashi, M. Ikawa, M. Okabe, N. Inoue, et al. 2007. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc. Natl. Acad. Sci. USA 104: 252-257. (Pubitemid 46068018)
11. Chin, A. I., A. K. Miyahira, A. Covarrubias, J. Teague, B. Guo, P. W. Dempsey, and G. Cheng. 2010. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance. Cancer Res. 70: 2595-2603.
12. Matsushima, H., N. Yamada, H. Matsue, and S. Shimada. 2004. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J. Immunol. 173: 531-541. (Pubitemid 38797381)
13. Lowe, D. B., M. H. Shearer, J. F. Aldrich, R. E. Winn, C. A. Jumper, and R. C. Kennedy. 2010. Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen. J. Virol. 84: 10121-10130.
14. Jiang, Q., H. Wei, and Z. Tian. 2008. IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma. J. Immunother. 31: 555-562.
15. Sorrentino, R., P. Gray, S. Chen, K. Shimada, T. R. Crother, and M. Arditi. 2010. Plasmacytoid dendritic cells prevent cigarette smoke and Chlamydophila pneumoniae-induced Th2 inflammatory responses. Am. J. Respir. Cell Mol. Biol. 43: 422-431.
16. Sorrentino, R., S. Morello, G. Forte, A. Montinaro, G. De Vita, A. Luciano, G. Palma, C. Arra, P. Maiolino, I. M. Adcock, and A. Pinto. 2011. B cells contribute to the antitumor activity of CpG-oligodeoxynucleotide in a mouse model of metastatic lung carcinoma. Am. J. Respir. Crit. Care Med. 183: 1369-1379.
17. Jeon, S. G., S. Y. Oh, H. K. Park, Y. S. Kim, E. J. Shim, H. S. Lee, M. H. Oh, B. Bang, E. Y. Chun, S. H. Kim, et al. 2007. TH2 and TH1 lung inflammation induced by airway allergen sensitization with low and high doses of doublestranded RNA. J. Allergy Clin. Immunol. 120: 803-812. (Pubitemid 47531833)
18. Jiang, Q., H. Wei, and Z. Tian. 2008. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway. BMC Cancer 8: 12.
19. Zhu, X., B. A. Fallert-Junecko, M. Fujita, R. Ueda, G. Kohanbash, E. R. Kastenhuber, H. A. McDonald, Y. Liu, P. Kalinski, T. A. Reinhart, et al. 2010. Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent manners. Cancer Immunol. Immunother. 59: 1401-1409.
20. Cheng, Y. S., and F. Xu. 2011. Anticancer function of polyinosinic-polycytidylic acid. Cancer Biol. Ther. 10: 1219-1223.
21. Trapani, J. A., and M. J. Smyth. 2002. Functional significance of the perforin/ granzyme cell death pathway. Nat. Rev. Immunol. 2: 735-747. (Pubitemid 37328714)
22. Longhi, M. P., C. Trumpfheller, J. Idoyaga, M. Caskey, I. Matos, C. Kluger, A. M. Salazar, M. Colonna, and R. M. Steinman. 2009. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206: 1589-1602.
23. Martin-Orozco, N., P. Muranski, Y. Chung, X. O. Yang, T. Yamazaki, S. Lu, P. Hwu, N. P. Restifo, W. W. Overwijk, and C. Dong. 2009. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31: 787-798.
24. Edwards, A. D., S. S. Diebold, E. M. Slack, H. Tomizawa, H. Hemmi, T. Kaisho, S. Akira, and C. Reis e Sousa. 2003. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 33: 827-833. (Pubitemid 36546669)
25. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.